Skip to main content
. 2015 Oct 12;2015:653840. doi: 10.1155/2015/653840

(b).

SD vaccine recipients HD vaccine recipients
Nonobese Obese p value Nonobese Obese p value
n = 64 n = 21 n = 64 n = 27
Seroconversion, % (95% CI)
 H1N1 59 (47–72) 62 (39–84) 0.84 81 (71–91) 63 (43–82) 0.06
 H3N2 75 (64–86) 71 (50–92) 0.74 78 (68–88) 85 (71–100) 0.44
 Influenza B 34 (22–46) 29 (8–50) 0.62 53 (40–66) 63 (43–82) 0.39
Seroprotection, % (95% CI)
 H1N1 86 (77–95) 90 (77–100) 0.59 98 (95–100) 89 (76–100) 0.04
 H3N2 91 (83–98) 100 (100–100) 0.15 97 (92–100) 93 (82–100) 0.36
 Influenza B 83 (73–92) 67 (45–89) 0.12 89 (81–97) 96 (89–100) 0.27
Prevaccination GMT (95% CI)
 H1N1 20 (11–37) 22 (7–67) 0.90 17 (9–30) 59 (23–154) 0.02
 H3N2 33 (20–55) 17 (6–48) 0.20 24 (13–43) 23 (10–54) 0.97
 Influenza B 16 (10–26) 18 (8–38) 0.84 18 (11–30) 20 (11–37) 0.86
Postvaccination GMT (95% CI)
 H1N1 307 (180–524) 386 (178–839) 0.66 684 (489–955) 746 (356–1570) 0.82
 H3N2 322 (202–515) 338 (192–667) 0.92 681 (439–1057) 771 (409–1456) 0.75
 Influenza B 63 (42–93) 60 (25–144) 0.92 149 (109–204) 122 (78–192) 0.48

BMI: body mass index; CI: confidence interval; GMT: geometric mean titer; HD: high dose; SD: standard dose.